Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005811 | lipid droplet | 5 | 1 |
GO:0016020 | membrane | 2 | 9 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4IA67
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 13 |
GO:0008152 | metabolic process | 1 | 13 |
GO:0009056 | catabolic process | 2 | 13 |
GO:0016042 | lipid catabolic process | 4 | 13 |
GO:0044238 | primary metabolic process | 2 | 13 |
GO:0071704 | organic substance metabolic process | 2 | 13 |
GO:1901575 | organic substance catabolic process | 3 | 13 |
GO:0006638 | neutral lipid metabolic process | 4 | 1 |
GO:0006639 | acylglycerol metabolic process | 5 | 1 |
GO:0006641 | triglyceride metabolic process | 6 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019433 | triglyceride catabolic process | 7 | 1 |
GO:0042592 | homeostatic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044242 | cellular lipid catabolic process | 4 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0046461 | neutral lipid catabolic process | 5 | 1 |
GO:0046464 | acylglycerol catabolic process | 6 | 1 |
GO:0046486 | glycerolipid metabolic process | 4 | 1 |
GO:0046503 | glycerolipid catabolic process | 5 | 1 |
GO:0048878 | chemical homeostasis | 4 | 1 |
GO:0055088 | lipid homeostasis | 5 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 13 |
GO:0016787 | hydrolase activity | 2 | 13 |
GO:0004806 | triglyceride lipase activity | 5 | 1 |
GO:0016298 | lipase activity | 4 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0052689 | carboxylic ester hydrolase activity | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 277 | 281 | PF00656 | 0.399 |
CLV_NRD_NRD_1 | 400 | 402 | PF00675 | 0.503 |
CLV_NRD_NRD_1 | 423 | 425 | PF00675 | 0.444 |
CLV_PCSK_KEX2_1 | 423 | 425 | PF00082 | 0.460 |
CLV_PCSK_KEX2_1 | 73 | 75 | PF00082 | 0.523 |
CLV_PCSK_PC1ET2_1 | 73 | 75 | PF00082 | 0.528 |
CLV_PCSK_SKI1_1 | 123 | 127 | PF00082 | 0.576 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.614 |
CLV_PCSK_SKI1_1 | 283 | 287 | PF00082 | 0.625 |
CLV_PCSK_SKI1_1 | 336 | 340 | PF00082 | 0.358 |
CLV_PCSK_SKI1_1 | 364 | 368 | PF00082 | 0.354 |
DOC_CDC14_PxL_1 | 412 | 420 | PF14671 | 0.674 |
DOC_MAPK_gen_1 | 283 | 291 | PF00069 | 0.459 |
DOC_MAPK_gen_1 | 383 | 393 | PF00069 | 0.576 |
DOC_MAPK_MEF2A_6 | 315 | 324 | PF00069 | 0.375 |
DOC_MAPK_MEF2A_6 | 35 | 42 | PF00069 | 0.388 |
DOC_PP1_RVXF_1 | 362 | 368 | PF00149 | 0.584 |
DOC_PP1_RVXF_1 | 71 | 78 | PF00149 | 0.315 |
DOC_PP2B_LxvP_1 | 247 | 250 | PF13499 | 0.308 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.541 |
DOC_USP7_UBL2_3 | 398 | 402 | PF12436 | 0.699 |
DOC_WW_Pin1_4 | 211 | 216 | PF00397 | 0.349 |
DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.496 |
DOC_WW_Pin1_4 | 416 | 421 | PF00397 | 0.629 |
LIG_14-3-3_CanoR_1 | 112 | 116 | PF00244 | 0.344 |
LIG_14-3-3_CanoR_1 | 167 | 173 | PF00244 | 0.354 |
LIG_14-3-3_CanoR_1 | 354 | 360 | PF00244 | 0.586 |
LIG_Actin_WH2_2 | 122 | 139 | PF00022 | 0.396 |
LIG_APCC_ABBA_1 | 320 | 325 | PF00400 | 0.368 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.547 |
LIG_BRCT_BRCA1_1 | 112 | 116 | PF00533 | 0.407 |
LIG_BRCT_BRCA1_1 | 381 | 385 | PF00533 | 0.595 |
LIG_deltaCOP1_diTrp_1 | 31 | 42 | PF00928 | 0.446 |
LIG_EH1_1 | 303 | 311 | PF00400 | 0.438 |
LIG_FHA_1 | 124 | 130 | PF00498 | 0.325 |
LIG_FHA_1 | 212 | 218 | PF00498 | 0.361 |
LIG_FHA_1 | 220 | 226 | PF00498 | 0.288 |
LIG_FHA_1 | 354 | 360 | PF00498 | 0.645 |
LIG_FHA_2 | 15 | 21 | PF00498 | 0.548 |
LIG_IRF3_LxIS_1 | 322 | 329 | PF10401 | 0.472 |
LIG_LIR_Gen_1 | 113 | 124 | PF02991 | 0.339 |
LIG_LIR_Gen_1 | 173 | 183 | PF02991 | 0.327 |
LIG_LIR_Gen_1 | 295 | 305 | PF02991 | 0.414 |
LIG_LIR_Gen_1 | 92 | 103 | PF02991 | 0.368 |
LIG_LIR_Nem_3 | 113 | 119 | PF02991 | 0.359 |
LIG_LIR_Nem_3 | 170 | 175 | PF02991 | 0.322 |
LIG_LIR_Nem_3 | 243 | 247 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 295 | 300 | PF02991 | 0.431 |
LIG_LIR_Nem_3 | 303 | 308 | PF02991 | 0.358 |
LIG_LIR_Nem_3 | 345 | 349 | PF02991 | 0.595 |
LIG_LIR_Nem_3 | 382 | 388 | PF02991 | 0.544 |
LIG_LIR_Nem_3 | 92 | 98 | PF02991 | 0.351 |
LIG_MYND_1 | 416 | 420 | PF01753 | 0.617 |
LIG_PCNA_yPIPBox_3 | 377 | 388 | PF02747 | 0.642 |
LIG_Pex14_1 | 47 | 51 | PF04695 | 0.281 |
LIG_Pex14_2 | 240 | 244 | PF04695 | 0.314 |
LIG_Pex14_2 | 48 | 52 | PF04695 | 0.343 |
LIG_SH2_CRK | 175 | 179 | PF00017 | 0.406 |
LIG_SH2_CRK | 255 | 259 | PF00017 | 0.380 |
LIG_SH2_CRK | 95 | 99 | PF00017 | 0.401 |
LIG_SH2_NCK_1 | 57 | 61 | PF00017 | 0.396 |
LIG_SH2_PTP2 | 313 | 316 | PF00017 | 0.410 |
LIG_SH2_PTP2 | 323 | 326 | PF00017 | 0.369 |
LIG_SH2_SRC | 297 | 300 | PF00017 | 0.442 |
LIG_SH2_STAT3 | 24 | 27 | PF00017 | 0.419 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.356 |
LIG_SH2_STAT5 | 269 | 272 | PF00017 | 0.321 |
LIG_SH2_STAT5 | 297 | 300 | PF00017 | 0.439 |
LIG_SH2_STAT5 | 313 | 316 | PF00017 | 0.302 |
LIG_SH2_STAT5 | 323 | 326 | PF00017 | 0.347 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.366 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.425 |
LIG_SH3_3 | 189 | 195 | PF00018 | 0.330 |
LIG_SH3_3 | 236 | 242 | PF00018 | 0.387 |
LIG_SH3_3 | 384 | 390 | PF00018 | 0.587 |
LIG_SUMO_SIM_par_1 | 218 | 226 | PF11976 | 0.327 |
LIG_SUMO_SIM_par_1 | 355 | 361 | PF11976 | 0.585 |
LIG_TRAF2_1 | 373 | 376 | PF00917 | 0.640 |
LIG_WRC_WIRS_1 | 169 | 174 | PF05994 | 0.401 |
MOD_CDK_SPK_2 | 211 | 216 | PF00069 | 0.375 |
MOD_CDK_SPxxK_3 | 416 | 423 | PF00069 | 0.638 |
MOD_CK1_1 | 11 | 17 | PF00069 | 0.503 |
MOD_CK1_1 | 170 | 176 | PF00069 | 0.403 |
MOD_CK1_1 | 211 | 217 | PF00069 | 0.397 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.544 |
MOD_CK1_1 | 358 | 364 | PF00069 | 0.563 |
MOD_CK1_1 | 369 | 375 | PF00069 | 0.603 |
MOD_CK1_1 | 379 | 385 | PF00069 | 0.611 |
MOD_CK1_1 | 396 | 402 | PF00069 | 0.630 |
MOD_CK2_1 | 197 | 203 | PF00069 | 0.420 |
MOD_CK2_1 | 293 | 299 | PF00069 | 0.438 |
MOD_CK2_1 | 369 | 375 | PF00069 | 0.661 |
MOD_Cter_Amidation | 399 | 402 | PF01082 | 0.480 |
MOD_Cter_Amidation | 71 | 74 | PF01082 | 0.549 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.511 |
MOD_GlcNHglycan | 150 | 153 | PF01048 | 0.612 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.532 |
MOD_GlcNHglycan | 407 | 410 | PF01048 | 0.490 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.543 |
MOD_GlcNHglycan | 80 | 83 | PF01048 | 0.390 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.496 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.514 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.357 |
MOD_GSK3_1 | 178 | 185 | PF00069 | 0.272 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.317 |
MOD_GSK3_1 | 36 | 43 | PF00069 | 0.327 |
MOD_GSK3_1 | 366 | 373 | PF00069 | 0.646 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.327 |
MOD_N-GLC_1 | 211 | 216 | PF02516 | 0.617 |
MOD_NEK2_1 | 168 | 173 | PF00069 | 0.381 |
MOD_NEK2_1 | 182 | 187 | PF00069 | 0.219 |
MOD_NEK2_1 | 326 | 331 | PF00069 | 0.413 |
MOD_NEK2_1 | 353 | 358 | PF00069 | 0.597 |
MOD_NEK2_1 | 393 | 398 | PF00069 | 0.653 |
MOD_NEK2_1 | 59 | 64 | PF00069 | 0.342 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.330 |
MOD_NEK2_2 | 111 | 116 | PF00069 | 0.423 |
MOD_PKA_2 | 111 | 117 | PF00069 | 0.327 |
MOD_PKA_2 | 178 | 184 | PF00069 | 0.389 |
MOD_PKA_2 | 353 | 359 | PF00069 | 0.631 |
MOD_PKA_2 | 376 | 382 | PF00069 | 0.575 |
MOD_PKA_2 | 75 | 81 | PF00069 | 0.361 |
MOD_Plk_1 | 219 | 225 | PF00069 | 0.386 |
MOD_Plk_1 | 231 | 237 | PF00069 | 0.367 |
MOD_Plk_1 | 36 | 42 | PF00069 | 0.299 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.336 |
MOD_Plk_4 | 156 | 162 | PF00069 | 0.393 |
MOD_Plk_4 | 178 | 184 | PF00069 | 0.355 |
MOD_Plk_4 | 240 | 246 | PF00069 | 0.325 |
MOD_Plk_4 | 293 | 299 | PF00069 | 0.432 |
MOD_ProDKin_1 | 211 | 217 | PF00069 | 0.352 |
MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.497 |
MOD_ProDKin_1 | 416 | 422 | PF00069 | 0.626 |
MOD_SUMO_for_1 | 196 | 199 | PF00179 | 0.415 |
MOD_SUMO_for_1 | 285 | 288 | PF00179 | 0.383 |
TRG_DiLeu_BaEn_1 | 307 | 312 | PF01217 | 0.362 |
TRG_DiLeu_BaLyEn_6 | 164 | 169 | PF01217 | 0.403 |
TRG_DiLeu_BaLyEn_6 | 280 | 285 | PF01217 | 0.396 |
TRG_DiLeu_BaLyEn_6 | 361 | 366 | PF01217 | 0.551 |
TRG_ENDOCYTIC_2 | 175 | 178 | PF00928 | 0.331 |
TRG_ENDOCYTIC_2 | 255 | 258 | PF00928 | 0.319 |
TRG_ENDOCYTIC_2 | 263 | 266 | PF00928 | 0.265 |
TRG_ENDOCYTIC_2 | 297 | 300 | PF00928 | 0.464 |
TRG_ENDOCYTIC_2 | 323 | 326 | PF00928 | 0.331 |
TRG_ENDOCYTIC_2 | 350 | 353 | PF00928 | 0.560 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.391 |
TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.399 |
TRG_ER_diArg_1 | 143 | 146 | PF00400 | 0.425 |
TRG_ER_diArg_1 | 235 | 238 | PF00400 | 0.386 |
TRG_ER_diArg_1 | 74 | 77 | PF00400 | 0.307 |
TRG_NES_CRM1_1 | 268 | 280 | PF08389 | 0.256 |
TRG_Pf-PMV_PEXEL_1 | 283 | 287 | PF00026 | 0.578 |
TRG_Pf-PMV_PEXEL_1 | 347 | 351 | PF00026 | 0.452 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P509 | Leptomonas seymouri | 75% | 100% |
A0A0S4IY58 | Bodo saltans | 34% | 100% |
A0A0S4J309 | Bodo saltans | 37% | 92% |
A0A1X0P9X6 | Trypanosomatidae | 45% | 100% |
A0A3S5H7X3 | Leishmania donovani | 100% | 100% |
A0A422N4J2 | Trypanosoma rangeli | 42% | 100% |
A4HB10 | Leishmania braziliensis | 81% | 100% |
C9ZM39 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9B580 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q2Q3 | Leishmania major | 93% | 100% |
V5DLV7 | Trypanosoma cruzi | 42% | 100% |